A Rubinstein

1.6k total citations
35 papers, 1.2k citations indexed

About

A Rubinstein is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A Rubinstein has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A Rubinstein's work include Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Lipid metabolism and disorders (7 papers). A Rubinstein is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Lipid metabolism and disorders (7 papers). A Rubinstein collaborates with scholars based in Israel, United States and Poland. A Rubinstein's co-authors include W. Virgil Brown, J C Gibson, Henry N. Ginsberg, Ngoc‐Anh Le, R A Norum, Ira J. Goldberg, Patsy Wang‐Iverson, Phillip Bukberg, M Liron and Adrian Iaina and has published in prestigious journals such as Journal of Clinical Investigation, Antimicrobial Agents and Chemotherapy and Journal of Lipid Research.

In The Last Decade

A Rubinstein

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Rubinstein Israel	16	671	607	441	216	213	35	1.2k
Nancy Phillips United States	12	501 0.7×	522 0.9×	266 0.6×	208 1.0×	137 0.6×	14	984
R M Krauss United States	17	716 1.1×	611 1.0×	263 0.6×	231 1.1×	168 0.8×	24	1.2k
A.H.M. Smelt Netherlands	23	764 1.1×	819 1.3×	445 1.0×	225 1.0×	277 1.3×	52	1.8k
Elisabet Vilella Spain	18	448 0.7×	492 0.8×	316 0.7×	141 0.7×	176 0.8×	35	1.4k
J D Morrisett United States	13	316 0.5×	440 0.7×	279 0.6×	142 0.7×	154 0.7×	18	928
Philip H. Frost United States	16	612 0.9×	408 0.7×	400 0.9×	171 0.8×	249 1.2×	22	1.2k
Carlo M. Barbagallo Italy	22	503 0.7×	747 1.2×	580 1.3×	173 0.8×	209 1.0×	100	1.6k
V. Mühlberger Austria	12	795 1.2×	880 1.4×	892 2.0×	205 0.9×	181 0.8×	26	1.9k
M van Linde-Sibenius Trip Netherlands	8	480 0.7×	706 1.2×	401 0.9×	216 1.0×	116 0.5×	8	1.2k
J. Frohlich Canada	16	388 0.6×	538 0.9×	177 0.4×	159 0.7×	185 0.9×	33	887

Countries citing papers authored by A Rubinstein

Since Specialization

Citations

This map shows the geographic impact of A Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rubinstein more than expected).

Fields of papers citing papers by A Rubinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rubinstein. The network helps show where A Rubinstein may publish in the future.

Co-authorship network of co-authors of A Rubinstein

This figure shows the co-authorship network connecting the top 25 collaborators of A Rubinstein. A scholar is included among the top collaborators of A Rubinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Rubinstein. A Rubinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubinstein, A, et al.. (2006). Feasibility of day-case vitreoretinal surgery. Eye. 22(2). 169–172. 12 indexed citations

Maharshak, Nitsan, Itzhak Shapira, Rivka Rotstein, et al.. (2002). The erythrocyte adhesiveness/aggregation test for the detection of an acute phase response and for the assessment of its intensity. Clinical & Laboratory Haematology. 24(4). 205–210. 7 indexed citations

Zeltser, David, Ori Rogowski, Renato Fusman, et al.. (2001). The Multiplicity of Atherosclerotic Risk Factors Corresponds to the Appearance of Increased Leukocyte Count in the Peripheral Blood: Relevance to the Pathogenesis of the Disease. European Journal of Cardiovascular Prevention & Rehabilitation. 8(6). 379–382. 3 indexed citations

Gavish, Dov, Eyal Leibovitz, I Shapira, & A Rubinstein. (2000). Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety. Journal of Internal Medicine. 247(5). 563–569. 71 indexed citations

Rubinstein, A, et al.. (2000). Efficacy and safety of cerivastatin 0.8 mg versus pravastatin 40 mg for treatment of dyslipidaemia. Atherosclerosis. 151(1). 74–74. 2 indexed citations

Harats, Dror & A Rubinstein. (2000). [Joint recommendations of Israel medical societies for prevention of coronary heart disease and atherosclerosis].. PubMed. 138(1). 66–74. 4 indexed citations

Grosskopf, Itamar, Hylton I. Miller, Gideon Charach, et al.. (1996). Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ. 312(7036). 935–939. 188 indexed citations

Arber, Nadir, Alon Grossman, Michael A. Hoffman, et al.. (1993). Epidemiology of achalasia in central israel rarity of esophageal cancer. Digestive Diseases and Sciences. 38(10). 1920–1925. 41 indexed citations

Rubinstein, A, Michael Koffler, Yael Villa, & E. Graff. (1993). The Gulf War and Diabetes Mellitus. Diabetic Medicine. 10(8). 774–776. 14 indexed citations

10.

Beigel, Yitzhak, Gerald J. Brook, S Eisenberg, et al.. (1993). Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.. PubMed. 29(5). 272–7. 5 indexed citations

11.

Rubinstein, A, et al.. (1992). Half-Mustache—A Clue to Peptic Ulcer?. Journal of Clinical Gastroenterology. 15(2). 96–98. 2 indexed citations

12.

Rubinstein, A & Ehud Arbit. (1990). Spinal cord blood flow in the rat under normal physiological conditions. Neurosurgery. 27(6). 882–882. 28 indexed citations

13.

Gibson, J C, Ronald Goldberg, A Rubinstein, et al.. (1987). Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 7(4). 401–407. 39 indexed citations

14.

Siegman‐Igra, Yardena, et al.. (1987). Visceral leishmaniasis presenting as fever of unknown origin.. PubMed. 39(1). 70–2. 4 indexed citations

15.

Fishel, B, T. Rosenbach, Michal Yaron, & A Rubinstein. (1986). Hyperlipidemias and rheumatic manifestations. Clinical Rheumatology. 5(1). 75–79. 1 indexed citations

16.

Gibson, J C, A Rubinstein, W. Virgil Brown, et al.. (1985). Apo E-containing lipoproteins in low or high density lipoprotein deficiency.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 5(4). 371–380. 14 indexed citations

17.

Rubinstein, A, J C Gibson, James R. Paterniti, et al.. (1985). Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.. Journal of Clinical Investigation. 75(2). 710–721. 74 indexed citations

18.

Rubinstein, A, et al.. (1981). Increase of the intestinal absorption of gentamicin and amikacin by a nonionic surfactant. Antimicrobial Agents and Chemotherapy. 19(5). 696–699. 10 indexed citations

19.

Heldenberg, D, et al.. (1981). Serum lipids and lipoprotein concentrations in young quadriplegic patients. Atherosclerosis. 39(2). 163–167. 24 indexed citations

20.

Jeannet, M, et al.. (1974). Prolonged remission of severe aplastic anemia after ALG pretreatment and HL-A-semi-incompatible bone-marrow cell transfusion.. PubMed. 6(4). 359–63. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact